Tauopathies are marked by pathological changes in the tau protein, whether it be mutations associated with inherited tauopathies (e.g. P301L mutant tau in FTDP-17)33 or post-translational modifications such as increased phosphorylation (e.g. the AT8 phospho-tau site)37,38. The gene discussed is MAPT; the disease is tauopathy.